Beginning its third year as an industry event, BioPharm America creates a robust exchange between hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.
The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in San Francisco, in September 2009, panel discussions included licensing, investment and business development executives from AstraZeneca, Bayer HealthCare, Biogen Idec, Eli Lilly, Exelixis, Roche, Genentech, Gilead, Johnson & Johnson, Merck & Co., Pfizer, Shire Takeda and UCB Pharma. The event attracted 700 delegates from 430 companies who participated in 1,550+ scheduled one-to-one meetings.
For information about the BioPharm America 2010 program and registration information, please register your email address for regular updates from EBD Group at update@ebdgroup.com.
Organizers:
EBD Group
Contact:
Holly Mersy
EBD Group, Inc.
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 930 0520
hmersy@ebdgroup.com
Website:
Industry:
Biotech
Key words:
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
Intended For:
Top international executives from:
- Established and emerging biotech companies
- Pharmaceutical companies
- Institutional financial firms
- Private investors including venture capital and private equity firms
Speakers:
tba – please see website
Cost:
http://www.ebdgroup.com/bpa/registration.htm
Program
See website.